26 Jun 2017 | 6:04 AM
 

Marksans Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524404 | NSE Symbol: MARKSANS
41.45
-1.45
(-3.38 %)
23 Jun 2017 | 03:57 PM
Change company
  • Open (Rs)
    42.30
  • Prev. close (Rs.)
    42.90
  • High (Rs.)
    43.10
  • Low (Rs.)
    41.15
  • 52W H (Rs.)
    58.30
  • 52W L (Rs.)
    36.96
  • Volume (Rs.)
    281799
  • MCap (Rs in Cr.)
    1,696.61
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
1.92
Operating Margin (%)
15.25
Gross Profit Margin (%)
12.10
Net Profit Margin (%)
8.78
Total Debt/Equity
0.20
Dividend payout Ratio (Net Profit)
22.87
Earning Retention Ratio
78.30

News

10 May 2017 - 16:40:00-Marksans Pharma Ltd an Indian pharma firm having global footprint on Wednesday said that its Goa fac...
26 Apr 2017 - 15:34:00-Marksans Pharma said that it has received certificate of GMP Compliance of a Manufacturer from Austr...
10 Apr 2017 - 14:27:00-Drug firm Marksans Pharma today said the US health regulator has issued four observations after comp...
06 Feb 2017 - 15:57:00-Marksans Pharma has reported of decline of 37 per cent in its consolidated net profit after taxes (P...

Announcements

29-May-2017
Marksans Pharma - Board recommends Dividend
29-May-2017
Marksans Pharma - Financial Result For The Period 31.03.2017
29-May-2017
Marksans Pharma - Outcome of Board Meeting
29-May-2017
Marksans Pharma - Updates
19-May-2017
Marksans Pharma - Board Meeting On 29.05.2017

Religare Research

23 Jun 2017 | 06:00 PM
This week, we haven’t recommended fresh position, keeping in mind overbought market condition and nu...
23 Jun 2017 | 06:00 PM
Nifty consolidated for yet another week and settled almost flat in the end, tracking mixed cues.
23 Jun 2017 | 11:34 AM
Agri Fundamental and Technical report
23 Jun 2017 | 09:57 AM
The Indian rupee fell to a more-than-three-week low against the dollar, weighed down by last-minute ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
6,68,725 6.05 24.80 -0.82
6,68,725 6.05 36.29 -0.82
6,68,725 6.05 38.14 -0.82
6,68,725 6.05 27.90 -0.82

Shareholding Pattern

       
Promotors48.25%
Mutual Funds/UTI0.00%
FI/Banks5.02%
Insurance5.02%
FII10.52%
Government0.00%
Others7.29%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,387.95(-0.10)
3578
 Kovai Medical Center and Hospital Ltd.
1,215.05(-1.20)
11816
 Merck Ltd.
1,085.00(-1.44)
3302
 AstraZeneca Pharma India Ltd.
915.00(-0.28)
3274

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Marksans Pharma Ltd.-5.25-6.101.10
NIFTY(S&P CNX)188.80488.651,589.20
BSE SENSEX772.961,806.055,097.51
BSE 500314.24752.842,426.41

Corporate Details

Key Personal
Mark Saldanha
Chairman & Managing Director
Sandra Saldanha
Whole Time Director
Vinay Gopal Nayak
Whole Time Director
Key Address
Registered Office
11th Floor Grandeur Veera Desai Extension Road Oshiwara Andheri (West),Mumbai,Maharashtra

Tel:022-40012000, Fax:022-40012011

info@marksanspharma.com
http://www.marksanspharma.com
Registrar Office
Bigshare Services Pvt. Ltd.
Add. :E/2 Ansa Industrial Estate Saki Vihar Road Saki Naka Andheri (E)

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Marksans Pharma Ltd. that will help you decide whether to buy, sell or hold Marksans Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Marksans Pharma Ltd.